/
GELS
$0.61+$0.02 (+2.98%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$6.6M
11M shares
52-week range
$0.39 – $2.02
14% from low
Exchange
NASDAQ
CS
Borrow rate
336.30%
Hard to borrow
Price (6 mo)
Loading chart…
Change$-2.30
Gelteq Limited Ordinary Shares
Gelteq Ltd is a clinical and science-based company focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products, preserving the simplicity, accessibility, and efficacy of oral delivery. Its principal products are edible gels and their application in gel-based dosage forms across pets, sports, pharmaceutical, over-the-counter, and nutraceutical categories, leveraging its patent pending multiple ingredient dosage forms. The company develops and tests gel-based delivery systems for humans and pets and focuses on out-licensing its technology to companies to create products that can be manufactured and sold, while continuing to manufacture existing products under license on a white label basis.
www.gelteq.com- Employees
- 8
- IPO / List date
- Oct 29, 2024
Held by traders on TradeandTell
No one on the platform currently holds GELS.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in GELS as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded GELS yet.
